StandardX

London deep-tech startup developing accelerator-based production systems for scarce medical, industrial and fusion isotopes.

🇬🇧
#isotopes#particle accelerators#nuclear medicine#advanced manufacturing
Visit website

About StandardX

StandardX is engineering a compact, high-power particle-accelerator platform intended to produce multiple isotopes from a standardized installation. Founded in 2025, it is initially focused on supply for cancer diagnostics and treatment, research and future fusion systems.

What StandardX offers

StandardX is developing a scalable production platform for rare isotopes used in medicine, industry and energy. Its compact particle-accelerator architecture is intended to produce a versatile portfolio including diagnostic and therapeutic medical isotopes, industrial isotopes and tritium for fusion energy.

What sets StandardX apart

StandardX is building a repeatable isotope-production platform rather than a facility dedicated to a single isotope. The compact accelerator architecture is designed to translate specialised nuclear physics into distributed, scalable production for materials that are currently scarce or constrained by centralised supply.

Launches from this company